Form 4: Hartford Financial Services Group EVP Michael Fisher Reports Stock Option Grant
SEC Form 4
EVP Michael R. Fisher of Hartford Financial Services Group reports the acquisition of stock options and direct ownership of common stock.
Summary
- On February 27, 2024, Michael R. Fisher, an Executive Vice President at Hartford Financial Services Group, reported changes in his beneficial ownership of the company's securities.
- Fisher acquired 6,306 stock options with an exercise price of $95.74, expiring on February 27, 2034.
- These options vest in three equal installments annually, starting February 27, 2025.
- Fisher directly owns 14,169.031 shares of Hartford Financial Services Group common stock.
- He also holds several other stock option grants from previous years with varying exercise prices and vesting schedules.
Sentiment
Score: 6
Explanation: The document is a routine regulatory filing detailing stock option grants, which is generally neutral. It reflects standard executive compensation practices.
Positives
- The granting of stock options to executives aligns their interests with those of shareholders, incentivizing them to improve company performance.
- Fisher's direct ownership of 14,169.031 shares demonstrates his investment in the company's success.
Future Outlook
The document does not contain specific forward-looking statements beyond the vesting schedules of the stock options.
Industry Context
Stock option grants are a common practice in the financial services industry to incentivize executives and align their interests with shareholders. The vesting schedules are designed to retain talent and encourage long-term performance.
Comparison to Industry Standards
- Stock option grants are a standard component of executive compensation packages in the insurance industry, similar to companies like Allstate, Progressive, and MetLife.
- The vesting schedules, typically three to four years, are also in line with industry norms.
- The exercise prices are generally set at or above the market price of the stock on the grant date.
Stakeholder Impact
- The stock option grant could potentially impact shareholders by diluting equity if the options are exercised.
- It incentivizes the executive to improve company performance, which could benefit shareholders.
Key Dates
| Date | Description |
|---|---|
| 02/25/2023 | Options became fully exercisable (granted 02/25/2020, $55.27) |
| 02/23/2023 | One-third of options became exercisable (granted 02/23/2019, $69.41) |
| 02/23/2024 | Options became fully exercisable (granted 02/23/2021, $51.87) |
| 02/23/2024 | An additional one-third of options became exercisable (granted 02/23/2019, $69.41) |
| 02/27/2024 | Date of transaction: Grant of 6,306 stock options at $95.74 |
| 02/28/2024 | One-third of options became exercisable (granted 02/28/2020, $78.28) |
| 02/27/2025 | One-third of new options become exercisable |
| 02/23/2025 | The remaining one-third of options will become exercisable (granted 02/23/2019, $69.41) |
| 02/28/2025 | An additional one-third of options will become exercisable (granted 02/28/2020, $78.28) |
| 02/27/2026 | An additional one-third of new options become exercisable |
| 02/28/2026 | The remaining one-third of options will become exercisable (granted 02/28/2020, $78.28) |
| 02/27/2027 | The remaining one-third of new options become exercisable |
| 02/23/2031 | Expiration date of options granted 02/23/2021 |
| 02/25/2030 | Expiration date of options granted 02/25/2020 |
| 02/23/2032 | Expiration date of options granted 02/23/2019 |
| 02/28/2033 | Expiration date of options granted 02/28/2020 |
| 02/27/2034 | Expiration date of new options granted 02/27/2024 |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.